Paper35778656
miR-1307-5p suppresses proliferation and tumorigenesis of bladder cancer via targeting MDM4 and the Hippo signaling pathway.
Huang W and 5 others. Discov Oncol, 2022. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. miR-1307-5p suppresses proliferation and tumorigenesis of bladder cancer via targeting MDM4 and the Hippo signaling pathway. Papers, record 35778656. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35778656
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- miR-1307-5p suppresses proliferation and tumorigenesis of bladder cancer via targeting MDM4 and the Hippo signaling pathway.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| No. 81860454 | National Natural Science Foundation of China | PubMed |
Source PubMed
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24745663 | Bladder cancer: a portal into men's health. | Urol Oncol | 2015 | https://conductscience.org/library/papers/24745663 | PubMed |
| 2 | 16492744 | Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo. | Proc Natl Acad Sci U S A | 2006 | https://conductscience.org/library/papers/16492744 | PubMed |
| 3 | 28109084 | miR-5195-3p Inhibits Proliferation and Invasion of Human Bladder Cancer Cells by Directly Targeting Oncogene KLF5. | Oncol Res | 2017 | https://conductscience.org/library/papers/28109084 | PubMed |
| 4 | 21304530 | The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. | Br J Cancer | 2011 | https://conductscience.org/library/papers/21304530 | PubMed |
| 5 | 27022975 | The Roles of MDM2 and MDMX in Cancer. | Annu Rev Pathol | 2016 | https://conductscience.org/library/papers/27022975 | PubMed |
| 6 | 26421824 | Urinary tract cancer survival in Europe 1999-2007: Results of the population-based study EUROCARE-5. | Eur J Cancer | 2015 | https://conductscience.org/library/papers/26421824 | PubMed |
| 7 | 28042869 | Genome-Wide Screen of miRNAs and Targeting mRNAs Reveals the Negatively Regulatory Effect of miR-130b-3p on PTEN by PI3K and Integrin β1 Signaling Pathways in Bladder Carcinoma. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/28042869 | PubMed |
| 8 | 25670033 | A genetic variant of MDM4 influences regulation by multiple microRNAs in prostate cancer. | Endocr Relat Cancer | 2015 | https://conductscience.org/library/papers/25670033 | PubMed |
| 9 | 32360052 | European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. | Eur Urol | 2021 | https://conductscience.org/library/papers/32360052 | PubMed |
| 10 | 31513891 | miR-1307-3p overexpression inhibits cell proliferation and promotes cell apoptosis by targeting ISM1 in colon cancer. | Mol Cell Probes | 2019 | https://conductscience.org/library/papers/31513891 | PubMed |
| 11 | 30207593 | Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2018 | https://conductscience.org/library/papers/30207593 | PubMed |
| 12 | 14744438 | MicroRNAs: genomics, biogenesis, mechanism, and function. | Cell | 2004 | https://conductscience.org/library/papers/14744438 | PubMed |
| 13 | 27375033 | Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. | Eur Urol | 2017 | https://conductscience.org/library/papers/27375033 | PubMed |
| 14 | 28440444 | miRNA-556-3p promotes human bladder cancer proliferation, migration and invasion by negatively regulating DAB2IP expression. | Int J Oncol | 2017 | https://conductscience.org/library/papers/28440444 | PubMed |
| 15 | 19219610 | The present and future burden of urinary bladder cancer in the world. | World J Urol | 2009 | https://conductscience.org/library/papers/19219610 | PubMed |
| 16 | 22265971 | MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression. | FEBS Lett | 2012 | https://conductscience.org/library/papers/22265971 | PubMed |
| 17 | 29311926 | Targeting the NFAT1-MDM2-MDMX Network Inhibits the Proliferation and Invasion of Prostate Cancer Cells, Independent of p53 and Androgen. | Front Pharmacol | 2017 | https://conductscience.org/library/papers/29311926 | PubMed |
| 18 | 29117157 | Bladder cancer: 4 big questions. | Nature | 2017 | https://conductscience.org/library/papers/29117157 | PubMed |
| 19 | 27698952 | Epigallocatechin-3-gallate Attenuates Renal Damage by Suppressing Oxidative Stress in Diabetic db/db Mice. | Oxid Med Cell Longev | 2016 | https://conductscience.org/library/papers/27698952 | PubMed |
| 20 | 28401709 | The role of microRNA-93 regulating angiopoietin2 in the formation of malignant pleural effusion. | Cancer Med | 2017 | https://conductscience.org/library/papers/28401709 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42106777 | miR-1307-5p mediates endothelial dysfunction and inflammation induced by acute coronary syndrome by targeting PIM3. | J Cardiothorac Surg | 2026 | https://conductscience.org/library/papers/42106777 | PubMed |
| 41827493 | Profiling miRNA in Systemic Lupus Erythematosus Patients Adhering to a Mediterranean Diet: An Interventional Pilot Study. | J Clin Med | 2026 | https://conductscience.org/library/papers/41827493 | PubMed |
| 41750312 | Tyrosine-Peptide Analog Modulates Extracellular Vesicles miRNAs Cargo from Mesenchymal Stem/Stromal and Cancer Cells to Drive Immunoregeneration and Tumor Suppression. | Biomolecules | 2026 | https://conductscience.org/library/papers/41750312 | PubMed |
| 41009639 | Comprehensive Profiling Identifies Circulating microRNA Dysregulation in Vietnamese Patients with Heart Failure. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41009639 | PubMed |
| 39883227 | Natural compounds as modulators of miRNAs: a new frontier in bladder cancer treatment. | Med Oncol | 2025 | https://conductscience.org/library/papers/39883227 | PubMed |
| 39744099 | Therapeutic Potential of Feline Adipose-Derived Stem Cell Exosomes in the Treatment of Feline Idiopathic Cystitis: A Characterization and Functional Analysis of miRNA Content. | Nanotheranostics | 2025 | https://conductscience.org/library/papers/39744099 | PubMed |
| 39006253 | Neurofibromin 2 modulates Mammalian Ste2-like kinases1/2 and large tumor suppressor gene1 expression in A549 lung cancer cell line. | Am J Transl Res | 2024 | https://conductscience.org/library/papers/39006253 | PubMed |
Genes16
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35778656
GET https://conductscience.org/api/papers/v1/35778656/references?page=2